NPI: 1801089495 · NEWARK, NY 14513 · Clinical Medical Laboratory · NPI assigned 08/27/2007
Authorized official TINCH, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | TINCH, PAULA (SVP-FINANCE) |
| Parent Organization | NEWARK WAYNE COMMUNITY HOSPITAL |
| NPI Enumeration Date | 08/27/2007 |
Other providers sharing the same authorized official: TINCH, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 648 | $16K |
| 2020 | 2,054 | $57K |
| 2021 | 12,088 | $404K |
| 2022 | 14,944 | $580K |
| 2023 | 11,430 | $337K |
| 2024 | 7,989 | $217K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5,336 | 5,154 | $399K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,175 | 3,122 | $238K |
| 87631 | 1,496 | 1,472 | $165K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,326 | 4,284 | $134K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,327 | 4,286 | $134K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,246 | 5,066 | $131K |
| 87634 | 1,353 | 1,337 | $74K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,346 | 1,324 | $60K |
| 87480 | 2,858 | 2,810 | $50K | |
| 87510 | 2,823 | 2,775 | $50K | |
| 87660 | 2,822 | 2,774 | $50K | |
| 87081 | 7,436 | 7,240 | $44K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,768 | 2,665 | $20K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 216 | 210 | $18K |
| 88142 | 609 | 605 | $16K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 354 | 353 | $11K |
| 87186 | 566 | 529 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 314 | 281 | $2K |
| 80053 | Comprehensive metabolic panel | 211 | 168 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 286 | 237 | $2K |
| 81001 | 685 | 668 | $2K | |
| 87077 | 189 | 177 | $2K | |
| 87150 | 51 | 51 | $2K | |
| 87088 | 183 | 176 | $1K | |
| 87070 | 126 | 125 | $963.93 | |
| 87641 | 12 | 12 | $371.16 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 12 | 12 | $359.76 |
| 82565 | 13 | 13 | $58.76 | |
| 84132 | 14 | 14 | $56.70 |